SAN DIEGO--(BUSINESS WIRE)--AltheaDx, Inc. is proud to announce that its co-founders, Magda Marquet, Ph.D., and Francois Ferre, Ph.D., have been selected as 2016 inductees into the CONNECT Entrepreneur Hall of Fame. CONNECT is a premier innovation company accelerator in San Diego that creates and scales great companies in the technology and life sciences sector. Induction into the CONNECT Entrepreneur Hall of Fame is the highest honor that CONNECT bestows. In addition, Dr. Marquet is being recognized as the first-ever female recipient of the award.
The pair is being honored for their extensive contributions within San Diego’s research, healthcare, and entrepreneur communities. An award dinner honoring Drs. Marquet and Ferre will be held on April 14, 2016, at the Estancia La Jolla Hotel.
“Magda and Francois epitomize true entrepreneurship and serve as great role models particularly in their commitment to help others in the community pursue our own entrepreneurial dreams. They are notable champions for nonprofit and industry advocacy,” said Greg Hamilton, CEO of AltheaDx. “Their unwavering efforts to the continued growth of the San Diego life sciences community make them the ideal selection for 2016.”
“Magda and Francois’ devotion to service and their altruism are among the qualities that I admire most as a colleague and friend,” said Jorge Garces, President of AltheaDx.
AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx’s IDgenetix® pharmacogenetic testing portfolio addresses some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. AltheaDx is a CAP-accredited, CLIA-certified laboratory located in San Diego, CA. For more information, visit www.altheadx.com.
This press release may contain forward-looking statements regarding the business strategy of AltheaDx. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that could cause actual levels of activity or performance to differ materially from those expressed or implied by these forward-looking statements. These statements reflect the views of AltheaDx as of the date of this press release with respect to future events and, except as required by law, it undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.